UK markets closed
  • FTSE 100

    7,017.47
    -135.96 (-1.90%)
     
  • FTSE 250

    22,324.19
    -210.95 (-0.94%)
     
  • AIM

    1,229.80
    -11.57 (-0.93%)
     
  • GBP/EUR

    1.1636
    -0.0053 (-0.46%)
     
  • GBP/USD

    1.3809
    -0.0115 (-0.83%)
     
  • BTC-GBP

    25,535.50
    -477.99 (-1.84%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • S&P 500

    4,166.45
    -55.41 (-1.31%)
     
  • DOW

    33,290.08
    -533.37 (-1.58%)
     
  • CRUDE OIL

    71.50
    +0.46 (+0.65%)
     
  • GOLD FUTURES

    1,763.90
    -10.90 (-0.61%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • HANG SENG

    28,801.27
    +242.68 (+0.85%)
     
  • DAX

    15,448.04
    -279.63 (-1.78%)
     
  • CAC 40

    6,569.16
    -97.10 (-1.46%)
     

$10.6 Billion Worldwide Short-Read Sequencing Industry to 2027 - Impact of COVID-19 on the Market

·2-min read

Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Short-Read Sequencing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Short-Read Sequencing estimated at US$10.6 Billion in the year 2020, is projected to reach a revised size of US$20.4 Billion by 2027, growing at a CAGR of 9.9% over the period 2020-2027.

Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sanger Sequencing segment is readjusted to a revised 10.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.1 Billion, While China is Forecast to Grow at 9.3% CAGR

The Short-Read Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.1% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Select Competitors (Total 32 Featured):

  • 10x Genomics

  • Agilent Technologies, Inc.

  • BGI

  • Eurofins Scientific

  • F. Hoffmann-La Roche Ltd

  • Fasteris

  • General Electric

  • Genewiz

  • GenScript

  • Illumina, Inc

  • Macrogen, Inc

  • Qiagen

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 32

For more information about this report visit https://www.researchandmarkets.com/r/50e96x

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting